Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
about
Antibody development against biologic agents used for the treatment of inflammatory bowel disease and antibody prevention with immunosuppressivesDanish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activityInflammatory bowel disease surgery in the biologic eraStatus of colitis-associated cancer in ulcerative colitisBenefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisEmerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseA Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel DiseasesGenetic update on inflammatory factors in ulcerative colitis: Review of the current literatureDiagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysisPillCam colon capsule endoscopy (PCCE) in colonic diseasesEfficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled TrialsDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesThe burden of inflammatory bowel disease in EuropeThe safety of vedolizumab for the treatment of ulcerative colitis.Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review.Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasoundNon-invasive evaluation of intestinal disorders: The role of elastographic techniques.High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational studyA retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: a study of Taiwan Society of Inflammatory Bowel Disease.Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.Mobile Phone Apps for Inflammatory Bowel Disease Self-Management: A Systematic Assessment of Content and Tools.Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare.Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Familial aggregation of inflammatory bowel disease in patients with ulcerative colitisEffectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.Opposing roles of prostaglandin D2 receptors in ulcerative colitisRelationship between methylation and colonic inflammation in inflammatory bowel disease.Differential expression of interleukin-1/Toll-like receptor signaling regulators in microscopic and ulcerative colitis.Working Group Guidelines on the nursing roles in caring for patients with Crohn's disease and ulcerative colitis in PolandEffectiveness of adalimumab for ambulatory ulcerative colitis patients after failure of infliximab treatment: a first "real-life" experience in primary gastroenterology centers in Italy.Performance of the Montreal classification for inflammatory bowel diseasesBudesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.Review article: acute severe ulcerative colitis - evidence-based consensus statements.Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies.Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis.Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel diseaseCharacterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.
P2860
Q24185835-2492E1EA-3B96-4406-8E01-7E34C1E166E1Q24658606-C2F0CE8C-168A-4A1D-A965-2D88EF7D1A82Q26745627-95BE17F1-410F-431D-B2E5-BF090DD16A95Q26751745-02A7FDAB-87B8-4DF2-B4C7-8766CFB50E3AQ26764801-5C623957-6E37-48F4-B91A-FB5CE93BD752Q26768273-CE2BE864-0F06-4FD5-A4C5-EC954D1C0DB8Q26775384-DE287A69-5122-4BF7-8AD5-52E271A610C6Q26852514-64D80182-5525-4149-8BFB-59754EE3A926Q28066449-798864D4-5FC2-4239-A335-A29DF15CFAEAQ28070100-10683B77-1A86-40C2-A343-10ED9B975538Q28070298-57723571-1EFF-4226-A696-5A6851DB9A19Q28085134-41EA1B40-2778-4E3F-A82C-5A8362B78F76Q28285200-99E8A0CB-32BD-459A-A674-CFBDD3C363AFQ30235363-EC5F3529-B81D-4008-BCCC-7045FFD969C9Q30248815-A4EEB87C-D2CE-48D6-BCD4-74420CABA71FQ30356090-F9349426-3901-4B24-8130-15CB55201ACEQ30356094-24C19FA8-25E5-4A12-91A6-104FF273B8DEQ30977032-1BFDDCF3-5446-4B2E-8752-8C524DB84529Q31004717-7990C544-3D28-418A-8BF1-98E593FA3BE8Q31115745-3EA0A3D5-A8CC-456A-A387-83C6B867D4B5Q31140142-DC315114-9C18-4DAF-BA15-5179FACA63CDQ33446999-CBCC31EB-A287-43E9-BA95-76457A2590E9Q33564081-E4FCD709-F200-4039-AB90-4C00BE9A363CQ33810058-AC80DEC3-7BF2-415F-87FB-DEE57D8EE4CFQ33819473-1576DDFC-10EC-4F91-97DC-7431F4ACD947Q33819525-D975B521-D5E4-4698-BDA8-72DD6D0EE0F1Q33843746-F200825A-13E3-4FD9-9D1D-C0EF26E616F6Q34001819-48A6763C-E686-4A1C-903A-5BEEAF7B535EQ34036817-C90F9EEA-F3EA-4457-8B16-13FF49AEB5C9Q34168594-2F304AC7-091D-4DB5-9230-8E25ABC485FEQ34258122-8FC80DB8-92A9-49C1-B38C-7A6B06F14D34Q34303155-E43EACCB-ED94-4C32-8F39-EE273DF17080Q34467297-00A7127C-8891-4EA8-A366-8F8AE56C6BE4Q34474024-B31D7AC8-1020-47C6-A74A-D2C658BBC69BQ34528270-039B332A-BD2C-41EB-9457-EE6CBC9A35D7Q35030705-0174A6C4-B606-41F9-A2B3-C362579AB639Q35069514-3CDB8EB1-32D9-4145-AEA6-AC41984E8B23Q35115895-AE7599C9-250B-45FE-8EDE-B8D7EEECBC08Q35692347-57BAA32E-4E5D-4EEB-94B6-BE07FED9B5F4Q35694271-612D49A8-CCA5-4E06-A909-732B5994B0AE
P2860
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Second European evidence-based ...... 1: definitions and diagnosis.
@en
type
label
Second European evidence-based ...... 1: definitions and diagnosis.
@en
prefLabel
Second European evidence-based ...... 1: definitions and diagnosis.
@en
P2093
P50
P1476
Second European evidence-based ...... 1: definitions and diagnosis.
@en
P2093
Christian Maaser
Gerassimos Mantzaris
James O Lindsay
Karel Geboes
Rami Eliakim
Simon Travis
Walter Reinisch
Yehuda Chowers
P304
P356
10.1016/J.CROHNS.2012.09.003
P577
2012-10-03T00:00:00Z